Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mirabella

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
International Archives of Allergy and Immunology|May 1, 1997
Interaction between histamine and nitric oxide in rat mast cells and in isolated guinea pig heartsP F Mannaioni, M G Bello, M G Di Bello, et al.
Minerva Cardioangiologica|June 15, 2004
[Usefulness of magnetic resonance imaging for the diagnosis of acute myocarditis. A case of acute myocarditis as myocardial infarction-like]G Portale, M Mazzone, P Fenici, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 30, 1998
A regulatory role for carbon monoxide in mast cell functionM G Di Bello, L Berni, P Gai, et al.
Analytical Biochemistry|February 4, 2014
Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activityOwen M Wilkins, Sondra L Downey, Emily S Weyburne, et al.
Plos One|March 9, 2022
Assessing healthcare provider knowledge of human traffickingNicole E Exeni McAmis, Angela C Mirabella, Elizabeth M McCarthy, et al.
Chemistry & Biology|May 26, 2011
Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomibAnne C Mirabella, Alexandre A Pletnev, Sondra L Downey, et al.
Haematologica|June 13, 2015
The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cellsMarianne Kraus, Juergen Bader, Paul P Geurink, et al.
Journal of Medicinal Chemistry|January 17, 2013
Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sitesPaul P Geurink, Wouter A van der Linden, Anne C Mirabella, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Archives of Allergy and Immunology|May 1, 1997
Interaction between histamine and nitric oxide in rat mast cells and in isolated guinea pig heartsP F Mannaioni, M G Bello, M G Di Bello, et al.
Minerva Cardioangiologica|June 15, 2004
[Usefulness of magnetic resonance imaging for the diagnosis of acute myocarditis. A case of acute myocarditis as myocardial infarction-like]G Portale, M Mazzone, P Fenici, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 30, 1998
A regulatory role for carbon monoxide in mast cell functionM G Di Bello, L Berni, P Gai, et al.
Analytical Biochemistry|February 4, 2014
Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activityOwen M Wilkins, Sondra L Downey, Emily S Weyburne, et al.
Plos One|March 9, 2022
Assessing healthcare provider knowledge of human traffickingNicole E Exeni McAmis, Angela C Mirabella, Elizabeth M McCarthy, et al.
Chemistry & Biology|May 26, 2011
Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomibAnne C Mirabella, Alexandre A Pletnev, Sondra L Downey, et al.
Haematologica|June 13, 2015
The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cellsMarianne Kraus, Juergen Bader, Paul P Geurink, et al.
Journal of Medicinal Chemistry|January 17, 2013
Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sitesPaul P Geurink, Wouter A van der Linden, Anne C Mirabella, et al.
Pageof 3